127 related articles for article (PubMed ID: 37558545)
1. Effect of Paxlovid on Tacrolimus Concentration in Perioperative Kidney Transplant Patients Infected With COVID-19: A Case Report.
Liu Y; Liu Y; Cai C; Hui F; Zhang Y; Wang B; Wang X; Zhang Y; Song X; He L; Yang H
Transplant Proc; 2023 Oct; 55(8):1822-1825. PubMed ID: 37558545
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
[TBL] [Abstract][Full Text] [Related]
3. Is microparticle enzyme-linked immunoassay (MEIA) reliable for use in tacrolimus TDM? Comparison of MEIA to liquid chromatography with mass spectrometric detection using longitudinal trough samples from transplant recipients.
Napoli KL
Ther Drug Monit; 2006 Aug; 28(4):491-504. PubMed ID: 16885716
[TBL] [Abstract][Full Text] [Related]
4. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
Tempestilli M; Di Stasio E; Basile MR; Elisei F; Antonini M; Ettorre GM; Iappelli M; Pucillo LP
Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
[TBL] [Abstract][Full Text] [Related]
5. Paxlovid (Nirmatelvir/Ritonavir) and Tacrolimus Drug-Drug Interaction in a Kidney Transplant Patient with SARS-2-CoV infection: A Case Report.
Prikis M; Cameron A
Transplant Proc; 2022; 54(6):1557-1560. PubMed ID: 35599203
[TBL] [Abstract][Full Text] [Related]
6. Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazards.
Rostaing L; Cointault O; Marquet P; Josse AG; Lavit M; Saint-Marcoux F; Kamar N
Transpl Int; 2010 Feb; 23(2):227-30. PubMed ID: 19761555
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
Saint-Marcoux F; Debord J; Parant F; Labalette M; Kamar N; Rostaing L; Rousseau A; Marquet P
Ther Drug Monit; 2011 Apr; 33(2):171-7. PubMed ID: 21383655
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of renal transplantation using liquid chromatographic monitoring of tacrolimus.
Borrows R; Chusney G; Loucaidou M; James A; Stichbury J; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
Ther Drug Monit; 2006 Apr; 28(2):269-73. PubMed ID: 16628143
[TBL] [Abstract][Full Text] [Related]
9. Accuracy evaluation of Roche and Siemens tacrolimus and cyclosporine assays in comparison with liquid chromatography-tandem mass spectrometry.
Ko DH; Cho EJ; Lee W; Chun S; Min WK
Scand J Clin Lab Invest; 2018 Oct; 78(6):431-438. PubMed ID: 30270673
[TBL] [Abstract][Full Text] [Related]
10. Elevated tacrolimus levels after treatment with nirmatrelvir/ritonavir (Paxlovid) for COVID-19 infection in a child with a kidney transplant.
Young C; Papiro T; Greenberg JH
Pediatr Nephrol; 2023 Apr; 38(4):1387-1388. PubMed ID: 35982345
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus trough monitoring guided by mass spectrometry without accounting for assay differences is associated with acute kidney injury in lung transplant recipients.
Kolaitis NA; Calabrese DR; Ahearn P; Venado A; Florez R; Lei HL; Isaak K; Henricksen E; Martinez E; Chong T; Shah RJ; Leard LE; Kleinhenz ME; Golden J; De Marco T; Greenland JR; Kukreja J; Hays SR; Blanc PD; Singer JP
Am J Health Syst Pharm; 2019 Dec; 76(24):2019-2027. PubMed ID: 31696925
[TBL] [Abstract][Full Text] [Related]
12. Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry.
Prémaud A; Rousseau A; Picard N; Marquet P
Ther Drug Monit; 2006 Apr; 28(2):274-7. PubMed ID: 16628144
[TBL] [Abstract][Full Text] [Related]
13. Liquid chromatography-tandem mass spectrometry method as the golden standard for therapeutic drug monitoring in renal transplant.
Aucella F; Lauriola V; Vecchione G; Tiscia GL; Grandone E
J Pharm Biomed Anal; 2013 Dec; 86():123-6. PubMed ID: 23995754
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the New Cyclosporine and Tacrolimus Automated Electrochemiluminescence Immunoassays under Field Conditions.
Toole B; Gechtman C; Dreier J; Kuhn J; Gutierrez MR; Barrett A; Niederau C
Clin Lab; 2015; 61(9):1303-15. PubMed ID: 26554251
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antibody-conjugated magnetic immunoassay and liquid chromatography-tandem mass spectrometry for the measurement of cyclosporine and tacrolimus in whole blood.
Cangemi G; Barco S; Bonifazio P; Maffia A; Agazzi A; Melioli G
Int J Immunopathol Pharmacol; 2013; 26(2):419-26. PubMed ID: 23755756
[TBL] [Abstract][Full Text] [Related]
16. The EMIT 2000 tacrolimus assay: an application protocol for the Beckman Synchron LX20 PRO analyzer.
LeGatt DF; Shalapay CE; Cheng SB
Clin Biochem; 2004 Nov; 37(11):1022-30. PubMed ID: 15498532
[TBL] [Abstract][Full Text] [Related]
17. Comparison of an ELISA and an LC/MS/MS method for measuring tacrolimus concentrations and making dosage decisions in transplant recipients.
Staatz CE; Taylor PJ; Tett SE
Ther Drug Monit; 2002 Oct; 24(5):607-15. PubMed ID: 12352932
[TBL] [Abstract][Full Text] [Related]
18. A comparison of liquid chromatography-tandem mass spectrometry (LC-MS/MS) and enzyme-multiplied immunoassay technique (EMIT) for the determination of the cyclosporin A concentration in whole blood from Chinese patients.
Li W; Li R; Liu H; Guo X; Shaikh AS; Li P; Wang B; Guo R; Zhang R
Biosci Trends; 2017 Sep; 11(4):475-482. PubMed ID: 28845016
[TBL] [Abstract][Full Text] [Related]
19. Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring.
Prémaud A; Rousseau A; Le Meur Y; Lachâtre G; Marquet P
Ther Drug Monit; 2004 Dec; 26(6):609-19. PubMed ID: 15570184
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Relationship Between Concentrations of Tacrolimus Metabolites, 13-O-Demethyl Tacrolimus and 15-O-Demethyl Tacrolimus, and Clinical and Biochemical Parameters in Kidney Transplant Recipients.
Zegarska J; Hryniewiecka E; Zochowska D; Samborowska E; Jazwiec R; Maciej K; Nazarewski S; Dadlez M; Paczek L
Transplant Proc; 2018 Sep; 50(7):2235-2239. PubMed ID: 30177142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
